318160.KQ Cell Bio Human Tech Co.,Ltd
- Market cap
- KRW 50.0B
- P/E
- 4.8x
- P/B
- 0.82x
- ROE
- 15.8%
- Dividend yield
- -
- Fundamental score
- 2.7/5
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 318160.KQ undervalued?
Graham number318160.KQ trades 58.0% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Cell Bio Human Tech Co.,Ltd fundamental analysis
13 of 22 checks passedROE 1/2
Moderate return on equity (15.8%), between 10% and 20%.
ROA 1/1
Return on assets (10.5%) is above the industry median (10.1%).
Profit Consistency 0/2
Not profitable for at least 3 consecutive years.
Earnings Growth 5Y 0/1
Earnings per share history is shorter than 5 years.
Earnings Acceleration 0/1
Not enough positive earnings history to compare last year's growth with the 5-year average.
Earnings Growth vs Industry 1/1
Last year's EPS growth (108.7%) is above the industry median (80.3%).
Revenue Growth 2/2
Revenue grew 22.8% a year over the past 3 years.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 2/2
Low debt to equity (20.2%), 40% or less.
Debt Trend 0/1
Debt to equity history is shorter than 5 years.
Debt Coverage 1/1
Operating cash flow covers 20% of total debt.
Interest Coverage 1/1
EBIT is 8.6x against interest expense, well covered.
PE vs Market 1/1
PE (4.8x) is below the market median (11.3x).
PE vs Industry 1/1
PE (4.8x) is below the industry median (12.4x).
PBV 1/1
Price to book (0.8x) is below the industry median (1.2x).
Graham Number 1/1
The price is below the Graham number (PE x PB = 4.0, limit 22.5).
PEG 0/1
PEG needs positive PE and positive 5-year earnings growth.
Dividend Yield 0/2
No dividend paid in the last reported year.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 0/1
No dividend, or no profit to pay it from.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
Cell Bio Human Tech Co.,Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Cell Bio Human Tech Co.,Ltd
Cell Bio Human Tech Co.,Ltd develops nonwoven fabric materials for sheet masks in Korea and Vietnam. The company provides sheet masks, patches, skincare products, etc. Its nonwoven fabric materials include PT CELL, a cellulose sheet made from bamboo; SEMI GEL and NC Cell, which are made of lyocell material; and SCell, which is made of rayon material, as well as cotton, microfiber, and PET. The company also offers dried hydrogel sheets and dried biocellulose fabrics. Cell Bio…
Full company profileCell Bio Human Tech Co.,Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Cell Bio Human Tech Co.,Ltd annual financial statements (KRW; K = thousand, M = million, B = billion, T = trillion)
| Item | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 27.5B | 27.3B | 28.4B | 51.1B | 64.2B |
| Gross Profit | 7.64B | 7.73B | 9.04B | 18.8B | 20.0B |
| Operating Income | 3.53B | 3.15B | 4.04B | 9.32B | 9.89B |
| EBITDA | 5.86B | 1.48B | 7.51B | 11.7B | 15.4B |
| Net Income | 2.89B | -1.86B | 4.38B | 8.72B | 9.68B |
| EPS | 413 | -201 | 513 | 1,070 | 1,156 |
| Balance Sheet | |||||
| Total Assets | 46.0B | 53.2B | 52.9B | 88.5B | 92.0B |
| Total Liabilities | 13.8B | 8.63B | 6.49B | 29.5B | 28.4B |
| Shareholders' Equity | 32.1B | 44.6B | 46.4B | 56.7B | 61.4B |
| Cash & Short-term Investments | 4.49B | 4.05B | 3.10B | 15.9B | 11.0B |
| Cash Flow | |||||
| Operating Cash Flow | 438M | 1.76B | 9.27B | 1.49B | 6.54B |
| Capital Expenditure | 375M | 1.13B | 2.03B | 6.81B | 18.5B |
| Free Cash Flow | 62.9M | 627M | 7.24B | -5.32B | -12.0B |
| Ratios | |||||
| ROE | 9.0% | -4.2% | 9.4% | 15.4% | 15.8% |
| ROA | 6.3% | -3.5% | 8.3% | 9.9% | 10.5% |
| Net Profit Margin | 10.5% | -6.8% | 15.4% | 17.1% | 15.1% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Cell Bio Human Tech Co.,Ltd dividends
Cell Bio Human Tech Co.,Ltd has not paid dividends in the last 4 fiscal years.
Who owns Cell Bio Human Tech Co.,Ltd
- Insiders 42.70%
- Institutions 2.48%
- Public & others 54.82%
- Shares outstanding 8.19M
- Free float 4.87M
Cell Bio Human Tech Co.,Ltd company profile
- Company name
- Cell Bio Human Tech Co.,Ltd
- Ticker
- 318160.KQ
- Exchange
- KOSDAQ
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- Employees
- 115
- Fiscal year end
- December
- Address
- #2101, 401 Simin-daero, Ansan-si, South Korea
- Phone
- 82 7 4786 9322
- Website
- cellbiohumantech.co.kr
About Cell Bio Human Tech Co.,Ltd
Cell Bio Human Tech Co.,Ltd develops nonwoven fabric materials for sheet masks in Korea and Vietnam. The company provides sheet masks, patches, skincare products, etc. Its nonwoven fabric materials include PT CELL, a cellulose sheet made from bamboo; SEMI GEL and NC Cell, which are made of lyocell material; and SCell, which is made of rayon material, as well as cotton, microfiber, and PET. The company also offers dried hydrogel sheets and dried biocellulose fabrics. Cell Bio Human Tech Co.,Ltd was founded in 2015 and is headquartered in Ansan-si, South Korea.
Cell Bio Human Tech Co.,Ltd management
4- Mr. KwonSun LeeCEO & Director · born 1973
- Mr. DongGyun ChaExecutive Director · born 1961
- CheolWoo SonExecutive Director · born 1975
- Mr. YongHo ChaExecutive Director · born 1975